x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

Key Biosafety Considerations for Coronavirus Research

Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:

Read Now
7 min. read
Read more
 
Blog

How Centralized IBC Review Can Benefit Gene Therapy Research

Gene therapy research is at the forefront of a coming boom in the clinical setting. Understand the growth, risks, and regulatory requirements here.

Read Now
4 min. read
Read more
 
Blog

Infection Control and Biosafety in Gene Therapy Research

Given the growth in gene therapy research, sponsors, CROs and sites have become increasingly curious about the requirements to be able to conduct such studies.

Read Now
4 min. read
Read more
 
Blog

IBC vs. IRB: What’s the Difference?

Gene therapy research is full of promise, but because of the risks, it’s a highly regulated space requiring oversight by an institutional biosafety committee (IBC).

Read Now
3 min. read
Read more
 
Blog

Planning Gene Therapy Research? Plan for IBC Review

The completion of the human genome project and advances in genetic engineering have paved the way for clinical trials involving human gene transfer

Read Now
4 min. read
Read more